News

Success for the Dunn School at the 2022 Vice Chancellor’s Environmental Sustainability Awards

July 2022

Dame Professor Louise Richardson hosted the 2022 Vice Chancellor’s Environmental Sustainability Awards, attended by staff and students from across the University of Oxford. The awards recognise and celebrate contributions towards the environmental goals of the University. 35 labs/facilities across the Dunn School were awarded LEAF status – with 9 receiving Gold, 16 receiving Silver and...

Read more

Ivan Ahel elected as a member of EMBO

July 2022

Prof Ivan Ahel’s leading contribution to the field ADP-ribosylation and genome stability has been recognised by his election to the membership of The European Molecular Biology Organization (EMBO).

Read more

Pulse to the beat: centrosome assembly requires a pulse of Polo kinase activity

June 2022

In a story published in the EMBO Journal, Wong, Wilmott et al. shed light on the mechanism of Polo action in the assembly of the centrosome. Cell division is an essential function of cells, and appropriate partitioning of DNA and other cellular materials is critical for the daughter cells’ functioning and survival. In animals, this process...

Read more

Company co-founded by Dunn School alumnus awarded £1.8 million to tackle Postoperative Delirium

June 2022

Dr Benjamin Dodsworth completed his PhD in the Dunn School and went on to co-found and become the Chief Scientific Officer of PIPRA (Pre-Interventional Preventive Risk Assessment) based in Zurich, Switzerland. Founded in 2019, PIPRA is a digital health company that aims to combat Postoperative Delirium, the most common post-surgical complication affecting 20% of patients...

Read more

Improved therapy for spinal muscular atrophy

June 2022

Published in Cell, a collaboration between the groups of Alberto Kornblihtt (Universidad de Buenos Aires, Argentina), Adrian Krainer (Cold Spring Harbor Laboratory, USA) and Nick Proudfoot (Dunn School) reports an improved treatment for spinal muscular atrophy. Spinal muscular atrophy (SMA) is a genetic disease of the central nervous system, causing muscle weakness and wasting. Affecting...

Read more

Novel insight into transcriptional functions of RNase H2 furthers our understanding of Aicardi Goutières Syndrome pathology

May 2022

Published in Nature Communications, work by the Gromak lab uncovers key new functions for RNase H2 during transcription, and provides molecular explanations for the pathology behind Aicardi Goutières Syndrome. Aicardi Goutières Syndrome (AGS) is a severe neuroinflammatory disease caused by mutations in RNase H2 in more than 50% of the cases. RNase H2 is an...

Read more

Prestigious BSCB prize for Iona Manley

May 2022

The Gruneberg lab student was recognised with the BSCB Young Cell Biologist of the Year Prize At the recent BSCB/BSDB joint spring conference at the University of Warwick, Iona Manley, a 4th year PhD student in the Gruneberg lab, won this year’s BSCB Young Cell Biologist of the Year Prize with her poster “A novel...

Read more

Susan Lea and Jordan Raff elected Fellows of the Royal Society

May 2022

Many congratulations to Susan and Jordan for this prestigious honour, recognising their contributions to structural and centrosome biology, respectively.

Read more

Andrii Gorelik awarded Wellcome Fellowship and Lincoln College Fellowship

April 2022

The prestigious fellowships will allow Dr Gorelik to conduct high-impact independent research on the exciting topic of cysteine ADP-ribosylation. Dr Andrii Gorelik of the Ahel group at the Dunn School was awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship from the Wellcome Trust and The Jones and Anson Junior Research Fellowship from Lincoln College, Oxford....

Read more

Jordan Raff receives Excellence in Science Award

April 2022

Awarded by the Biochemical Society, this honour recognises his leading role in the field of centriole and centrosome biology.

Read more

ADP-ribosylation of DNA in vivo revealed for the first time

March 2022

A study by the Ivan Ahel group reports the existence of ADP-ribosylation of DNA in vivo and its role in the regulation of bacterial growth. This research could have strong implications for the treatment of tuberculosis. ADP-ribosylation is a modification of macromolecules found across all domains of life and regulates a variety of cellular processes...

Read more

Dunn School strengthens its research on bacterial pathogenesis

March 2022

Dr Georgia Isom and Dr Mathew Stracy lead two new research groups in the Dunn School. March marks the beginning of a new phase at the Dunn School with the arrival of two new research groups, led by Dr Georgia Isom and Dr Mathew Stracy. Both Dr Isom and Dr Stracy have secured highly competitive...

Read more

Antibiotic-prescribing algorithm reduces the risk of antibiotic resistance emergence in patients

February 2022

New paper by the Stracy group uses machine learning to predict individual risk and develop personalised treatment strategies Antibiotics have saved countless lives but their widespread use has led to antibiotic resistance which is increasing throughout the world and threatens our ability to treat dangerous bacterial infections. Despite the significant health and economic burden, little...

Read more

Ivan Ahel appointed Professor of Chemical Pathology

February 2022

We are delighted to announce that Dr Ivan Ahel has been appointed to the E.P. Abraham Chair of Chemical Pathology, in association with Lincoln College.

Read more

Green Group celebrates High Sheriff Award

February 2022

The AWARD recognises efforts to embed sustainable environmental practices across the department The Dunn School Green Group were joint winners of the High Sheriff’s Climate Action Heroes Awards, in the business/public sector category. The award was announced at a ceremony at the Oxford Trust’s Wood Centre for Innovation in Headington Quarry, Oxford on Monday 21 February. Dunn School Gr...

Read more